Philip Lazarovici

11PUBLICATIONS
9CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cheminformatics and quantitative structure-activity relationshipsMolecular targetsPharmacogenomicsBiomolecular modelling and design
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jul 15, 2026
Correction: Cohen et al. Near Infrared Optical Visualization of Epidermal Growth Factor Receptors Levels in COLO205 Colorectal Cell Line, Orthotopic Tumor in Mice and Human Biopsies. Int. J. Mol. Sci. 2013, 14, 14669-14688.

|Sep 27, 2025
RETRACTED: Naamneh et al. Structure-Activity Relationship of Synthetic Linear KTS-Peptides Containing Meta-Aminobenzoic Acid as Antagonists of α1β1 Integrin with Anti-Angiogenic and Melanoma Anti-Tumor Activities. Pharmaceuticals 2024, 17, 549.

Majdi Saleem Naamneh, Tatjana Momic, Michal Klazas

|Sep 02, 2025
Antitumor Activity of Alexidine Dihydrochloride Nanocarriers in Renal Cell Carcinoma.

Adan Sultan, Amani Zoabi, Anna Morshin

|Jul 27, 2024
Rasagiline Exerts Neuroprotection towards Oxygen-Glucose-Deprivation/Reoxygenation-Induced GAPDH-Mediated Cell Death by Activating Akt/Nrf2 Signaling.

Shimon Lecht, Adi Lahiani, Michal Klazas

|Jun 27, 2024
Development of Clarstatin, a Novel Drug Lead for the Therapy of Autoimmune Uveitis.

Shira Merzbach, Amnon Hoffman, Philip Lazarovici

|May 25, 2024
RETRACTED: Structure-Activity Relationship of Synthetic Linear KTS-Peptides Containing Meta-Aminobenzoic Acid as Antagonists of α1β1 Integrin with Anti-Angiogenic and Melanoma Anti-Tumor Activities.

Majdi Saleem Naamneh, Tatjana Momic, Michal Klazas

Pageof 2

Frequent Collaborators

4 joint publications

Majdi Saleem Naamneh

3 joint publications

Amnon Hoffman

3 joint publications

Chaim Gilon

2 joint publications

Johannes A Eble